1. Home
  2. PHVS vs SA Comparison

PHVS vs SA Comparison

Compare PHVS & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • SA
  • Stock Information
  • Founded
  • PHVS 2015
  • SA 1979
  • Country
  • PHVS Netherlands
  • SA Canada
  • Employees
  • PHVS N/A
  • SA N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • SA Precious Metals
  • Sector
  • PHVS Health Care
  • SA Basic Materials
  • Exchange
  • PHVS Nasdaq
  • SA Nasdaq
  • Market Cap
  • PHVS 862.3M
  • SA 991.5M
  • IPO Year
  • PHVS 2021
  • SA N/A
  • Fundamental
  • Price
  • PHVS $16.91
  • SA $11.66
  • Analyst Decision
  • PHVS Strong Buy
  • SA
  • Analyst Count
  • PHVS 5
  • SA 0
  • Target Price
  • PHVS $41.60
  • SA N/A
  • AVG Volume (30 Days)
  • PHVS 50.2K
  • SA 1.5M
  • Earning Date
  • PHVS 05-07-2025
  • SA 03-28-2025
  • Dividend Yield
  • PHVS N/A
  • SA N/A
  • EPS Growth
  • PHVS N/A
  • SA N/A
  • EPS
  • PHVS N/A
  • SA N/A
  • Revenue
  • PHVS N/A
  • SA N/A
  • Revenue This Year
  • PHVS N/A
  • SA N/A
  • Revenue Next Year
  • PHVS N/A
  • SA N/A
  • P/E Ratio
  • PHVS N/A
  • SA N/A
  • Revenue Growth
  • PHVS N/A
  • SA N/A
  • 52 Week Low
  • PHVS $14.14
  • SA $10.14
  • 52 Week High
  • PHVS $26.57
  • SA $20.55
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 55.23
  • SA 51.50
  • Support Level
  • PHVS $14.49
  • SA $10.30
  • Resistance Level
  • PHVS $17.00
  • SA $11.96
  • Average True Range (ATR)
  • PHVS 1.32
  • SA 0.60
  • MACD
  • PHVS 0.18
  • SA 0.07
  • Stochastic Oscillator
  • PHVS 71.95
  • SA 83.52

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About SA Seabridge Gold Inc. (Canada)

Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.

Share on Social Networks: